Credit Suisse Ag Jazz Pharmaceuticals PLC Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Credit Suisse Ag holds 143,776 shares of JAZZ stock, worth $16 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

143,776

Previous 133,491 7.7%

Holding current value

$16 Million

Previous $16.4 Million 5.44%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$115.19 - $132.77 $1.18 Million - $1.37 Million	10,285 Added 7.7%	143,776 $17.3 Million
Q4 2023 Feb 08, 2024	SELL	$114.26 - $136.0 $148,309 - $176,528	-1,298 Reduced 0.96%	133,491 $16.4 Million
Q3 2023 Nov 13, 2023	SELL	$122.0 - $145.31 $380,884 - $453,657	-3,122 Reduced 2.26%	134,789 $17.4 Million
Q2 2023 Aug 11, 2023	SELL	$122.5 - $147.16 $1.13 Million - $1.36 Million	-9,223 Reduced 6.27%	137,911 $17.1 Million
Q1 2023 May 10, 2023	BUY	$133.98 - $160.47 $3.95 Million - $4.73 Million	29,500 Added 25.08%	147,134 $21.5 Million
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $1.09 Million - $1.34 Million	8,409 Added 7.7%	117,634 $18.7 Million
Q3 2022 Nov 10, 2022	BUY	$126.59 - $161.18 $1.98 Million - $2.53 Million	15,673 Added 16.75%	109,225 $14.6 Million
Q2 2022 Aug 12, 2022	SELL	$141.59 - $168.66 $606,713 - $722,708	-4,285 Reduced 4.38%	93,552 $14.6 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $88,284 - $109,436	681 Added 0.7%	97,837 $15.2 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $550,443 - $668,916	-4,592 Reduced 4.51%	97,156 $12.4 Million
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $3.49 Million - $5.01 Million	-27,116 Reduced 21.04%	101,748 $13.2 Million
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $371,824 - $432,680	-2,321 Reduced 1.77%	128,864 $22.9 Million
Q1 2021 May 14, 2021	BUY	$150.19 - $173.5 $3.4 Million - $3.93 Million	22,655 Added 20.87%	131,185 $21.6 Million
Q4 2020 Feb 12, 2021	SELL	$140.71 - $165.05 $1.87 Million - $2.2 Million	-13,308 Reduced 10.92%	108,530 $17.9 Million
Q3 2020 Nov 13, 2020	SELL	$105.46 - $144.13 $1.74 Million - $2.37 Million	-16,477 Reduced 11.91%	121,838 $17.4 Million
Q2 2020 Aug 12, 2020	SELL	$95.68 - $121.88 $8.13 Million - $10.4 Million	-84,944 Reduced 38.05%	138,315 $15.3 Million
Q1 2020 May 13, 2020	BUY	$87.74 - $152.74 $4.21 Million - $7.33 Million	48,015 Added 27.4%	223,259 $22.3 Million
Q4 2019 Feb 12, 2020	BUY	$117.65 - $153.73 $10.8 Million - $14.1 Million	91,606 Added 109.53%	175,244 $26.2 Million
Q3 2019 Nov 12, 2019	SELL	$125.18 - $143.24 $1.98 Million - $2.26 Million	-15,798 Reduced 15.89%	83,638 $10.7 Million
Q2 2019 Aug 14, 2019	SELL	$125.55 - $144.48 $755,434 - $869,336	-6,017 Reduced 5.71%	99,436 $14.2 Million
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $1.06 Million - $1.25 Million	8,712 Added 9.01%	105,453 $15.1 Million
Q4 2018 Feb 13, 2019	BUY	$115.94 - $166.74 $406,021 - $583,923	3,502 Added 3.76%	96,741 $12 Million
Q3 2018 Nov 13, 2018	BUY	$161.01 - $180.57 $347,459 - $389,670	2,158 Added 2.37%	93,239 $15.7 Million
Q2 2018 Aug 14, 2018	BUY	$146.33 - $183.18 $32,631 - $40,849	223 Added 0.25%	91,081 $15.7 Million
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $14,372 - $16,658	-106 Reduced 0.12%	90,858 $13.7 Million
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $2.87 Million - $3.3 Million	21,930 Added 31.77%	90,964 $12.2 Million
Q3 2017 Nov 14, 2017	SELL	$142.62 - $155.6 $4.18 Million - $4.56 Million	-29,337 Reduced 29.82%	69,034 $10.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	98,371	98,371 $15.3 Million

Others Institutions Holding JAZZ

# of Institutions

490

Shares Held

57M

Call Options Held

155K

Put Options Held

152K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.99B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account